androstenedione has been researched along with ssr 125543a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auchus, RJ; Chan, JL; Davis, SM; Farber, RH; Fechner, PY; Giri, N; Imel, EA; Roberts, E; Sarafoglou, K; Sturgeon, J; Vogiatzi, MG | 1 |
| Auchus, RJ; Chan, JL; Farber, RH; Fechner, PY; Giri, N; Jeha, GS; Newfield, RS; Nokoff, NJ; Roberts, E; Sarafoglou, K; Sturgeon, J; Vogiatzi, MG | 1 |
1 trial(s) available for androstenedione and ssr 125543a
| Article | Year |
|---|---|
Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Administration, Oral; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Androstenedione; Azabicyclo Compounds; Biomarkers; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Oxadiazoles; Receptors, Corticotropin-Releasing Hormone; Testosterone; Treatment Outcome; Young Adult | 2022 |
1 other study(ies) available for androstenedione and ssr 125543a
| Article | Year |
|---|---|
Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Androgens; Androstenedione; Female; Humans; Male; Testosterone | 2023 |